FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...

Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins "Squawk Box' to discuss the latest market trends, ...

RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...

Fintel reports that on February 4, 2025, RBC Capital downgraded their outlook for Olin (NYSE:OLN) from Outperform to Sector ...

In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...

Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...

J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...

RBC Capital Markets head of global energy research Greg Pardy has made two changes to his Global Energy Best Ideas list, ...

RBC Capital Mkts has recently raised SAGE Therapeutics Inc (SAGE) stock to Sector Perform rating, as announced on November 21, 2024, according to Finviz. Earlier, on October 10, 2 ...

Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.

Neumora Therapeutics Inc (NMRA) stock saw a modest uptick, ending the day at $1.91 which represents a slight increase of $0.05 or 2.69% from the prior close of $1.86. The stock opened at $1.87 and ...